Hematology Analyzer Market

Report Code: MDS087A

Publish Date: Jul 2023

Publisher: BCC Publishing

Category: Medical Devices And Surgical

Download Report Overview

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for hematology analyzers is estimated to increase from $4.0 billion in 2023 to reach $5.3 billion by 2028, at a compound annual growth rate (CAGR) of 5.7% from 2023 through 2028.

Report Includes

  • 19 data tables and 45 additional tables
  • An overview of global market outlook for hematology analyzers
  • Analyses of global market trends, with data from 2020-2023 and projections of compound annual growth rates (CAGRs) through 2028
  • Identification of market trends, issues and forecast impacting the global hematology analyzers market and quantification of the market based on product/service, end user, and region
  • Discussion on market drivers such as growing incidence of blood disorders, increased preference for automated hematology instruments, and technological advancements in hematology analyzers
  • Discussion on recent advancements and innovations available in the market
  • Comprehensive company profiles of key players in the market, including Abbott, Boule Diagnostics AB, EKF Diagnostics Holdings Plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corp., and Nihon Kohden Corp.

Report Scope

The current report provides detailed exposure to the hematology analyzer market. This report highlights the current and future market potential of hematology analyzers, along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections through 2028 and market rank for key players. It covers the competitive environment, regulatory scenario and outlines market share based on product/service and end user. Products/services include Instruments, Reagents and Consumables and Services. The market end users are hospitals and clinics, diagnostic centers, research institutes and other end users. This report includes company profiles of key players with detailed information on business segments, financials, product portfolios and recent developments. The report examines the impact of the COVID-19 pandemic on this market.

By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $3.8 billion
Market size forecast $5.3 billion
Growth rate CAGR of 5.7% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered product/service, end user, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered U.S., Canada, Germany, U.K., France, Italy, China, Japan, and India
Key Market Drivers
  • High Prevalence of Blood Disorders
  • Rising Adoption of Automation
  • Technological Advancements
Companies studied
ABBOTTBIO-RAD LABORATORIES INC.
BOULE DIAGNOSTICS ABDANAHER CORP.
DIATRONEKF DIAGNOSTICS HOLDINGS PLC
HORIBA LTD.NIHON KOHDEN CORP.
NORMA INSTRUMENTSSHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
SIEMENS HEALTHINEERS AGSYSMEX CORP.
TRANSASIA BIO-MEDICALSTRIVITRON HEALTHCARE
WIENER LABORATORIOS SAIC
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for hematology analyzers was valued at $4.0 billion in 2023 and is projected to reach $5.3 billion by the end of 2028 at a CAGR of 5.7%.
The key factors driving the growth of the hematology analyzer market include the high prevalence of blood disorders, increasing adoption of automated methods, and technological advancements.
The hematology analyzer market is segmented based on product/service, end-user, and region.
Reagents & Consumables will dominate the market by the end of 2028.
North America holds the highest share of the market.
Key companies in the market include Sysmex Corporation, Danaher, Abbott, Mindray, Siemens Healthineers AG, BioRad, Boule Diagnostics, Diatron, EKF Diagnostics, Horiba, and Nihon Kohden.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Hematology Analyzer Market144Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background11Free
Chapter- 4: Market Dynamics6Free
Chapter- 5: Industry Overview15Free
Chapter- 6: Impact of the COVID-19 Pandemic3Free
Chapter- 7: Clinical Trial Analysis4Free
Chapter- 8: Patent Review5Free
Chapter- 9: Emerging Technologies in the Market2Free
Chapter- 10: Market Breakdown by Product/Service16Free
Chapter- 11: Market Breakdown by End User8Free
Chapter- 12: Market Breakdown by Region20Free
Chapter- 13: Competitive Landscape9Free
Chapter- 14: Company Profiles36Free

Related Reports

Drugs and Diagnostics for Hematological Disorders: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - PHM116C

The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.

In Vitro Diagnostics (IVD) Analyzers: Global Market

Published - Jan 2024 | Publisher - BCC Publishing | Code - MDS061B

The global market for In Vitro Diagnostics (IVD) analyzers is estimated to increase from $12.9 billion in 2023 to reach $16.3 billion by 2028, at a compound annual growth rate (CAGR) of 4.7% from 2023 through 2028.

Recent Reports

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

Published - Nov 2024 | Publisher - Gundreddy Gopinadh | Code - MDS008B

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

Global Medical Tapes Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - MDS105A

The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.

Global Prenatal Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS103A

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Global Skin Allergy Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS104A

The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Hematology Analyzer Market
Sample Report